IL99899A0 - Vaccines - Google Patents

Vaccines

Info

Publication number
IL99899A0
IL99899A0 IL99899A IL9989991A IL99899A0 IL 99899 A0 IL99899 A0 IL 99899A0 IL 99899 A IL99899 A IL 99899A IL 9989991 A IL9989991 A IL 9989991A IL 99899 A0 IL99899 A0 IL 99899A0
Authority
IL
Israel
Prior art keywords
vaccines
Prior art date
Application number
IL99899A
Other languages
English (en)
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of IL99899A0 publication Critical patent/IL99899A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL99899A 1991-03-21 1991-10-30 Vaccines IL99899A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919106048A GB9106048D0 (en) 1991-03-21 1991-03-21 Vaccines

Publications (1)

Publication Number Publication Date
IL99899A0 true IL99899A0 (en) 1992-08-18

Family

ID=10691984

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99899A IL99899A0 (en) 1991-03-21 1991-10-30 Vaccines

Country Status (12)

Country Link
CN (1) CN1064891A (fi)
AP (1) AP368A (fi)
BR (1) BR9107294A (fi)
CZ (1) CZ195793A3 (fi)
FI (1) FI934133A0 (fi)
GB (1) GB9106048D0 (fi)
HU (2) HUT67011A (fi)
IL (1) IL99899A0 (fi)
MA (1) MA22381A1 (fi)
SK (1) SK82593A3 (fi)
WO (1) WO1992016556A1 (fi)
YU (1) YU174491A (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
PL178578B1 (pl) * 1993-03-23 2000-05-31 Smithkline Beecham Biolog Zawiesina cząstek 3-0-deacylowanego monofosforylolipidu A i sposób jej wytwarzania oraz kompozycja szczepionki zawierającej antygen w połączeniu z 3-0-deacylowanym monofosforylolipidem A i sposób jej wytwarzania
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
CN1304580C (zh) * 2004-07-09 2007-03-14 楼伟 重组表达人获得性免疫缺陷病毒I型的表面糖蛋白gp160
WO2006011060A2 (en) * 2004-07-23 2006-02-02 Chiron Srl Polypeptides for oligomeric assembly of antigens
NZ553776A (en) 2004-09-22 2010-05-28 Glaxosmithkline Biolog Sa Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide.
WO2008104803A2 (en) 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Proteins
EP3118221B1 (en) 2007-02-26 2019-08-21 Oxford BioTherapeutics Ltd Proteins
AU2010207552A1 (en) 2009-01-21 2011-09-01 Oxford Biotherapeutics Ltd. PTA089 protein
EP2496605A1 (en) 2009-11-02 2012-09-12 Oxford Biotherapeutics Ltd. Ror1 as therapeutic and diagnostic target
JP6113721B2 (ja) 2011-06-28 2017-04-12 オックスフォード ビオトヘラペウトイクス エルティーディー． 治療標的及び診断標的
GB201213364D0 (en) 2012-07-27 2012-09-12 Glaxosmithkline Biolog Sa Purification process
GB201213652D0 (en) 2012-08-01 2012-09-12 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
GB201302447D0 (en) 2013-02-12 2013-03-27 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
JP2018511655A (ja) 2015-03-20 2018-04-26 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ボルデテラ属に対するワクチン接種における使用のための免疫原性組成物
ES2929054T3 (es) 2016-05-16 2022-11-24 Access To Advanced Health Inst Formulación que contiene un agonista de TLR y métodos de uso
CA3023672A1 (en) 2016-05-16 2017-11-23 Infectious Disease Research Institute Pegylated liposomes and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein

Also Published As

Publication number Publication date
AP368A (en) 1994-10-28
FI934133A (fi) 1993-09-21
HU9302642D0 (en) 1994-01-28
WO1992016556A1 (en) 1992-10-01
GB9106048D0 (en) 1991-05-08
AP9100332A0 (en) 1992-01-31
MA22381A1 (fr) 1992-07-01
CZ195793A3 (en) 1994-05-18
BR9107294A (pt) 1994-06-14
YU174491A (sh) 1994-06-10
HUT67011A (en) 1995-01-30
SK82593A3 (en) 1994-01-12
CN1064891A (zh) 1992-09-30
FI934133A0 (fi) 1993-09-21

Similar Documents

Publication Publication Date Title
ZA922011B (en) Vaccine
GR3024242T3 (en) Vaccines
AP9300541A0 (en) Vaccines
AP9300530A0 (en) Vaccines
IL99899A0 (en) Vaccines
GB9215233D0 (en) Vaccines
GB9202933D0 (en) Vaccines
GB9213559D0 (en) Vaccines
GB9214871D0 (en) Vaccines
GB9201023D0 (en) Vaccines
GB9226768D0 (en) Vaccines
GB9105993D0 (en) Vaccines
GB9121208D0 (en) Vaccines
GB9119167D0 (en) Vaccines
GB9119009D0 (en) Vaccines
ZA926088B (en) Vaccines
GB9110067D0 (en) Vaccines
GB9124390D0 (en) Vaccines
GB9211081D0 (en) Vaccines
GB9006097D0 (en) Vaccines
GB9011358D0 (en) Vaccines
GB9216317D0 (en) Vaccines
GB9218833D0 (en) Vaccines
GB9220360D0 (en) Vaccines
GB9221891D0 (en) Vaccines